An insulin-loaded emulsion system (IES) was developed as a hypoglycaemic drug for transmucosal delivery. The selected formulation was a stable oil/water emulsion system. The particles in the emulsion system were distr...An insulin-loaded emulsion system (IES) was developed as a hypoglycaemic drug for transmucosal delivery. The selected formulation was a stable oil/water emulsion system. The particles in the emulsion system were distributed evenly, and the particle size ranged from 20 to 260 nm (average size: 67.5 nm). Soybean lecithin played an important role in the emulsion system due to its abilities of acting as both absorption enhancer for insulin uptake through sublingual mucosa and oily phase for the emulsion system. The laser confocal scanning microscopic (LCSM) study showed that FITC-labelled insulin could penetrate the sublingual mucosa of rabbits, and the phase diagrams of the emulsion system suggested that soybean lecithin could take the place of oily phase to construct a stable emulsion system even if the traditional oil was absent. The applications of soybean lecithin as pharmaceutical biomaterial were extended for the further usage by present studies.展开更多
the composites of grafting polystyrene polyvinyl acetate (PVA) or polyethylene terephthalate (PET) coated with soybean lecithin, are obtained. Results of grafting experiments show that the grafting ratio on the surfac...the composites of grafting polystyrene polyvinyl acetate (PVA) or polyethylene terephthalate (PET) coated with soybean lecithin, are obtained. Results of grafting experiments show that the grafting ratio on the surface of the fibers is low when the grafting polymer chain is not cross linked. Under scanning electron microscope (SEM), it is discovered that there is no different morphology between the raw fibers and their being coated with soybean lecithin. The composites exhibit a good stability of soybean lecithin layer, and better anti coagulant property than the sulfonated grafting fibers or raw fibers.展开更多
文摘An insulin-loaded emulsion system (IES) was developed as a hypoglycaemic drug for transmucosal delivery. The selected formulation was a stable oil/water emulsion system. The particles in the emulsion system were distributed evenly, and the particle size ranged from 20 to 260 nm (average size: 67.5 nm). Soybean lecithin played an important role in the emulsion system due to its abilities of acting as both absorption enhancer for insulin uptake through sublingual mucosa and oily phase for the emulsion system. The laser confocal scanning microscopic (LCSM) study showed that FITC-labelled insulin could penetrate the sublingual mucosa of rabbits, and the phase diagrams of the emulsion system suggested that soybean lecithin could take the place of oily phase to construct a stable emulsion system even if the traditional oil was absent. The applications of soybean lecithin as pharmaceutical biomaterial were extended for the further usage by present studies.
文摘the composites of grafting polystyrene polyvinyl acetate (PVA) or polyethylene terephthalate (PET) coated with soybean lecithin, are obtained. Results of grafting experiments show that the grafting ratio on the surface of the fibers is low when the grafting polymer chain is not cross linked. Under scanning electron microscope (SEM), it is discovered that there is no different morphology between the raw fibers and their being coated with soybean lecithin. The composites exhibit a good stability of soybean lecithin layer, and better anti coagulant property than the sulfonated grafting fibers or raw fibers.
